Regeneron Pharmaceuticals Inc. (REGN)

Index:

Nasdaq 100

$ 588.34
   
  • Change Today:
    $-8.51
  • 52 Week High: $1,201.76
  • 52 Week Low: $571.06
  • Currency: US Dollars
  • Shares Issued: 107.80m
  • Volume: 656,257
  • Market Cap: $63,423m
  • RiskGrade: 129

Fundamentals - based on IFRS

  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Income Statement 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20
Continuing Operations          
Revenue 14,202.00 13,117.20 12,172.90 16,071.70 8,497.10
Operating Profit/(Loss) 3,990.70 4,047.10 4,738.90 8,946.80 3,576.60
Profit Before Tax 4,779.90 4,199.30 4,858.80 9,325.80 3,810.40
Profit After Tax 4,412.60 3,953.60 4,338.40 8,075.30 3,513.20
           
Earnings per Share - Basic 4,090.00¢ 3,705.00¢ 4,051.00¢ 7,640.00¢ 3,265.00¢
Earnings per Share - Adjusted 4,090.00¢ 3,705.00¢ 4,051.00¢ 7,640.00¢ 3,265.00¢
           
Dividend per Share n/a n/a n/a n/a n/a
  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Balance Sheet 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20
Assets          
Non-Current Assets          
Property, Plant & Equipment 4,599.70 4,146.40 3,763.00 3,482.20 3,221.60
Intangible Assets 1,148.60 1,038.60 915.50 6.70 n/a
Other Non-Current Assets 13,350.20 8,416.00 8,651.90 7,931.00 4,162.60
  19,098.50 13,601.00 13,330.40 11,419.90 7,384.20
Current Assets          
Inventories 3,087.30 2,580.50 2,401.90 1,951.30 1,916.60
Cash at Bank & in Hand 2,488.20 2,730.00 3,105.90 2,885.60 2,193.70
Other Current Assets 13,085.40 14,168.70 10,376.30 9,178.00 5,668.80
  18,660.90 19,479.20 15,884.10 14,014.90 9,779.10
           
Other Assets n/a n/a n/a n/a n/a
Total Assets 37,759.40 33,080.20 29,214.50 25,434.80 17,163.30
Current Liabilities          
Borrowings 3,944.30 3,423.40 n/a 719.70 n/a
Other Current Liabilities n/a n/a 3,141.30 3,212.80 3,442.30
           
Current Liabilities 3,944.30 3,423.40 3,141.30 3,932.50 3,442.30
           
Net Current Assets c14,716.60 c16,055.80 c12,742.80 c10,082.40 c6,336.80
           
Borrowings 2,704.40 2,702.90 2,701.40 1,980.00 2,695.70
Other Non-Current Liabilities 1,757.10 980.80 707.80 753.50 n/a
Non-Current Liabilities 4,461.50 3,683.70 3,409.20 2,733.50 2,695.70
           
Other Liabilities n/a n/a n/a n/a n/a
Total Liabilities 8,405.80 7,107.10 6,550.50 6,666.00 6,138.00
           
Net Assets 29,353.60 25,973.10 22,664.00 18,768.80 11,025.30
           
Shareholders Funds 29,353.60 25,973.10 22,664.00 18,768.80 11,025.30
           
Minority Interests/Other Equity n/a n/a n/a n/a n/a
Total Equity 29,353.60 25,973.10 22,664.00 18,768.80 11,025.30
Cash Flow 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20
Net Cash Flow From Operating Activities 4,420.50 4,594.00 5,014.90 1,010.20 2,618.10
Net Cash Flow from Investing Activities (2,468.10) (3,185.10) (3,784.60) (7,107.32) (70.60)
Net Cash Flow from Financing Activities (2,201.20) (1,790.50) (1,009.00) 5,914.65 (1,970.50)
Net Increase/Decrease In Cash (248.80) (381.60) 221.30 (182.48) 577.00
Ratios - based on IFRS 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20
Continuing Operations          
PE Ratio - Adjusted 17.4 23.7 17.8 8.3 14.8
PEG - Adjusted 1.7 n/a n/a 0.1 0.2
Earnings per Share Growth - Adjusted 10% -8% -47% 134% 68%
Dividend Cover n/a n/a n/a n/a n/a
Revenue per Share 13,174.40¢ 12,168.09¢ 11,292.11¢ 150.49¢ 7,882.28¢
Pre-Tax Profit per Share 4,434.04¢ 3,895.45¢ 4,507.23¢ 87.32¢ 3,534.69¢
Operating Margin 28.10% 30.85% 38.93% 55.67% 42.09%
Return on Capital Employed 13.71% 13.52% 19.87% 0.44% 27.77%
           
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0%
Dividend per Share Growth n/a n/a n/a n/a n/a
Operating Cash Flow per Share 4,100.65¢ 4,261.60¢ 4,652.04¢ 937.10¢ 2,428.66¢
Cash Incr/Decr per Share (230.80¢) (353.99¢) 205.29¢ (1.71¢) 535.25¢
Net Asset Value per Share (exc. Intangibles) 26,164.19¢ 23,130.33¢ 20,174.86¢ 17,404.55¢ 10,227.55¢
Net Gearing 14.17% 13.08% -1.78% -0.99% 4.55%

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

Top of Page